Here are the strategies of Novo’s rivals
![Foto: Colourbox](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article4909143.ece/ALTERNATES/schema-16_9/verden.jpg)
Sanofi and Eli Lilly are at two different stages at the moment. In the drug Lantus, Sanofi has the world’s by far bestselling diabetes drug – in fact, with a sales increase of 1.4 billion dollars it was the global pharmaceutical industry’s fastest growing drug in 2012. Eli Lilly, on the other hand, is in the process of returning to the lead group after having fallen behind within diabetes in recent years.
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.